{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T01:33:41Z","timestamp":1773106421647,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Nanjing youth talent cultivation plan of Chinese medicine","award":["ZYQ20038"],"award-info":[{"award-number":["ZYQ20038"]}]},{"name":"Natural Science Foundation of Nanjing University of Traditional Chinese Medicine","award":["XZR2021044"],"award-info":[{"award-number":["XZR2021044"]}]},{"name":"Jiangsu Key Research and Development Program (Social Development) Project","award":["BE2021611"],"award-info":[{"award-number":["BE2021611"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The adenoma-adenocarcinoma pathway represents a crucial mechanism underlying the development of colorectal precancerous lesions, encompassing approximately 85%-90% of colorectal cancer (CRC). Elucidating the molecular mechanisms underlying colorectal cancer progression is of paramount importance for achieving early and accurate diagnosis as well as effective treatment. We collected peripheral blood mononuclear cells (PBMC) from healthy controls, adenoma patients, and adenocarcinoma patients, and performed transcriptomic profiling to characterize dynamic gene expression during carcinogenesis. Diagnostic potential was assessed using receiver operating characteristic (ROC) analysis, and a random-forest model was trained to classify disease status. The screening identified genes with consistent expression changes as potential early diagnostic markers, and further exploration of their functions and significance in CRC is conducted through analysis of the TCGA database. The findings revealed that the progression of precancerous lesions in the \u201cNormal-Adenoma-Cancer\u201d (N-A-C) sequence was accompanied by a sustained enhancement of the immune response. Notably, HECW2, WARS1, SLC16A3, SECTM1, IFITM3, ADAMTSL4, FCGR1A, F2RL1, OPLAH, SERPINA1, FCGR1CP showed consistent upregulation with promising diagnostic performance. In our PBMC cohort, the random-forest classifier achieved an accuracy of 93.62%, indicating potential for distinguishing cancer from precancerous lesions. The bioinformatics analysis revealed a significant association of these genes with DNA methyltransferase, DNA mismatch repair, m6A regulator, tumor mutational burden (TMB) and microsatellite instability (MSI). Furthermore, a detailed analysis was further performed on WARS1. In the \u201cN-A-C\u201d sequence, WARS1 exhibited a significant upregulation in both blood and tissues, demonstrating a positive correlation with augmented infiltration of immune cells, activation of stromal and immune responses, as well as heightened activity during the cancer immune cycle. However, it demonstrates a declining trend in the progression of CRC from stage I to IV, which may be intricately associated with the metastasis of CRC. The WARS1 can serve as a reliable indicator of the immune response in CRC, thereby demonstrating its potential to impede tumorigenesis or metastasis.<\/jats:p>","DOI":"10.1038\/s41598-025-21401-y","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:10:16Z","timestamp":1761574216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Progressively altered genes in colorectal carcinogenesis link oncogenesis immune cycle and tumor microenvironment"],"prefix":"10.1038","volume":"15","author":[{"given":"Bingwen","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingrui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuyue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueyang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"21401_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/EDBK_438466","volume":"44","author":"PS Pathak","year":"2024","unstructured":"Pathak, P. S., Chan, G., Deming, D. A. & Chee, C. E. State-of-the-Art management of colorectal cancer. ASCO Educ. Book. 44, 1\u201315. https:\/\/doi.org\/10.1200\/EDBK_438466 (2024).","journal-title":"ASCO Educ. Book."},{"issue":"2","key":"21401_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1470-2045(23)00646-0","volume":"25","author":"R De Angelis","year":"2024","unstructured":"De Angelis, R. et al. Complete cancer prevalence in Europe in 2020 by disease phase: prevalence, mortality, and trends. Lancet Oncol. 25 (2), 123\u2013135. https:\/\/doi.org\/10.1016\/S1470-2045(23)00646-0 (2024).","journal-title":"Lancet Oncol."},{"issue":"8","key":"21401_CR3","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/cancers16081530","volume":"16","author":"G Roshandel","year":"2024","unstructured":"Roshandel, G. et al. Colorectal cancer: Epidemiology, risk factors, and prevention. Cancers 16 (8), 1530. https:\/\/doi.org\/10.3390\/cancers16081530 (2024).","journal-title":"Cancers"},{"issue":"11","key":"21401_CR4","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41575-019-0209-8","volume":"16","author":"SH Wong","year":"2019","unstructured":"Wong, S. H. & Yu, J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat. Rev. Gastroenterol. Hepatol. 16 (11), 690\u2013704. https:\/\/doi.org\/10.1038\/s41575-019-0209-8 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"11","key":"21401_CR5","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1056\/NEJMra1513581","volume":"374","author":"WB Strum","year":"2016","unstructured":"Strum, W. B. Colorectal adenomas. N. Engl. J. Med. 374 (11), 1065\u20131075. https:\/\/doi.org\/10.1056\/NEJMra1513581 (2016).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"21401_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5217\/ir.2023.00112","volume":"22","author":"HM Kim","year":"2024","unstructured":"Kim, H. M. et al. Screening and surveillance for hereditary colorectal cancer syndromes. Intest Res. 22 (1), 60\u201372. https:\/\/doi.org\/10.5217\/ir.2023.00112 (2024).","journal-title":"Intest Res."},{"issue":"17","key":"21401_CR7","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.3390\/cancers16172967","volume":"16","author":"L Brandaleone","year":"2024","unstructured":"Brandaleone, L. et al. Hereditary colorectal cancer syndromes and inflammatory bowel diseases: risk management and surveillance strategies. Cancers 16 (17), 2967. https:\/\/doi.org\/10.3390\/cancers16172967 (2024).","journal-title":"Cancers"},{"issue":"3","key":"21401_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/his.12055","volume":"63","author":"M Bettington","year":"2013","unstructured":"Bettington, M. et al. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology 63 (3), 367\u2013386. https:\/\/doi.org\/10.1111\/his.12055 (2013).","journal-title":"Histopathology"},{"issue":"4","key":"21401_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrclinonc.2010.18","volume":"7","author":"M Hewish","year":"2010","unstructured":"Hewish, M., Lord, C. J., Martin, S. A., Cunningham, D. & Ashworth, A. Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nat. Rev. Clin. Oncol. 7 (4), 197\u2013208. https:\/\/doi.org\/10.1038\/nrclinonc.2010.18 (2010).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"21401_CR10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/codi.15886","volume":"23","author":"JC Nielsen","year":"2021","unstructured":"Nielsen, J. C., Ploug, M., Baatrup, G. & Kroijer, R. Risk of post-colonoscopy colorectal cancer following screening colonoscopy with low-risk or no adenomas: a population-based study. Colorectal Dis. 23 (3), 630\u2013643. https:\/\/doi.org\/10.1111\/codi.15886 (2021).","journal-title":"Colorectal Dis."},{"key":"21401_CR11","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasim, P. M. & Wallace, M. B. Colorectal cancer. Lancet 394, 1467\u20131480. https:\/\/doi.org\/10.1016\/S0140-6736(19)32319-0 (2019).","journal-title":"Lancet"},{"key":"21401_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nchembio.1158","volume":"9","author":"M Guo","year":"2013","unstructured":"Guo, M. & Schimmel, P. Essential nontranslational functions of tRNA synthetases. Nat. Chem. Biol. 9, 145\u2013153. https:\/\/doi.org\/10.1038\/nchembio.1158 (2013).","journal-title":"Nat. Chem. Biol."},{"issue":"32","key":"21401_CR13","doi-asserted-by":"publisher","first-page":"11043","DOI":"10.1073\/pnas.0802862105","volume":"105","author":"SG Park","year":"2008","unstructured":"Park, S. G., Schimmel, P. & Kim, S. Aminoacyl tRNA synthetases and their connections to disease. Proc. Natl. Acad. Sci. USA. 105 (32), 11043\u201311049. https:\/\/doi.org\/10.1073\/pnas.0802862105 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"21401_CR14","doi-asserted-by":"publisher","first-page":"e2103","DOI":"10.21769\/BioProtoc.2103","volume":"7","author":"A Puleo","year":"2017","unstructured":"Puleo, A., Carroll, C., Maecker, H. T. & Gupta, R. Isolation of peripheral blood mononuclear cells using Vacutainer\u00ae cellular Preparation tubes (CPT\u2122). Bio Protoc. 7 (2), e2103. https:\/\/doi.org\/10.21769\/BioProtoc.2103 (2017).","journal-title":"Bio Protoc."},{"issue":"5795","key":"21401_CR15","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313 (5795), 1960\u20131964. https:\/\/doi.org\/10.1126\/science.1129139 (2006).","journal-title":"Science"},{"issue":"10135","key":"21401_CR16","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","volume":"391","author":"F Pag\u00e8s","year":"2018","unstructured":"Pag\u00e8s, F. et al. International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet 391 (10135), 2128\u20132139. https:\/\/doi.org\/10.1016\/S0140-6736(18)30789-X (2018).","journal-title":"Lancet"},{"issue":"10","key":"21401_CR17","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/s41591-018-0157-9","volume":"24","author":"N Auslander","year":"2018","unstructured":"Auslander, N. et al. Robust prediction of response to immune checkpoint Blockade therapy in metastatic melanoma. Nat. Med. 24 (10), 1545\u20131549. https:\/\/doi.org\/10.1038\/s41591-018-0157-9 (2018).","journal-title":"Nat. Med."},{"key":"21401_CR18","doi-asserted-by":"publisher","unstructured":"Shao, Y. et al. Drug co-administration in the tumor immune microenvironment of Hepatocellular carcinoma. Acupuncture and Herbal Medicine. 3 (3), 189\u2013199 (2023). https:\/\/doi.org\/10.1097\/HM9.0000000000000074","DOI":"10.1097\/HM9.0000000000000074"},{"key":"21401_CR19","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture form expression data. Nat. Commun. 4, 2612. https:\/\/doi.org\/10.1038\/ncomms3612 (2013).","journal-title":"Nat. Commun."},{"key":"21401_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7. https:\/\/doi.org\/10.1186\/1471-2105-14-7 (2013).","journal-title":"BMC Bioinform."},{"issue":"1","key":"21401_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen, D. S. & Mellman, I. Oncology meets immunology: the cancer-immunity cycle. Immunity 39 (1), 1\u201310. https:\/\/doi.org\/10.1016\/j.immuni.2013.07.012 (2013).","journal-title":"Immunity"},{"issue":"23","key":"21401_CR22","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.1158\/0008-5472.CAN-18-0689","volume":"78","author":"L Xu","year":"2018","unstructured":"Xu, L. et al. TIP: A web server for resolving tumor immunophenotype profiling. Cancer Res. 78 (23), 6575\u20136580. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0689 (2018).","journal-title":"Cancer Res."},{"issue":"10","key":"21401_CR23","doi-asserted-by":"publisher","first-page":"e13091","DOI":"10.1371\/journal.pone.0013091","volume":"5","author":"M Skrzypczak","year":"2010","unstructured":"Skrzypczak, M. et al. Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. Plos One. 5 (10), e13091. https:\/\/doi.org\/10.1371\/journal.pone.0013091 (2010).","journal-title":"Plos One"},{"key":"21401_CR24","unstructured":"Reumers, J. et al. Gene expression data of patients presenting with concurrent colorectal adenomas and colorectal tumors were obtained using Affymetrix U133\u2009+\u2009arrays. GEO datasets. (2018)."},{"issue":"11","key":"21401_CR25","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A., Lin, D., Assenov, Y., Plass, C. & Koeffler, H. P. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28 (11), 1747\u20131756. https:\/\/doi.org\/10.1101\/gr.239244.118 (2018).","journal-title":"Genome Res."},{"key":"21401_CR26","doi-asserted-by":"publisher","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12 (4), R41 (2011). https:\/\/doi.org\/10.1186\/gb-2011-12-4-r41","DOI":"10.1186\/gb-2011-12-4-r41"},{"issue":"1","key":"21401_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1158\/2159-8290.CD-14-0863","volume":"5","author":"NJ Llosa","year":"2015","unstructured":"Llosa, N. J. et al. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 5 (1), 43\u201351. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0863 (2015).","journal-title":"Cancer Discov"},{"key":"21401_CR28","doi-asserted-by":"publisher","first-page":"101091","DOI":"10.1016\/j.neo.2024.101091","volume":"59","author":"SA Ferkel","year":"2025","unstructured":"Ferkel, S. A. et al. Tumor-infiltrating immune cells in colorectal cancer: immune subtypes, prognostic role and biomarker profiling. Neoplasia 59, 101091. https:\/\/doi.org\/10.1016\/j.neo.2024.101091 (2025).","journal-title":"Neoplasia"},{"issue":"7693","key":"21401_CR29","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan, S. et al. TGF\u03b2 attenuates tumour response to PD-L1 Blockade by contributing to exclusion of T cells. Nature 554 (7693), 544\u2013548. https:\/\/doi.org\/10.1038\/nature25501 (2018).","journal-title":"Nature"},{"issue":"5","key":"21401_CR30","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L., Han, Y. & He, Q. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16 (5), 284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118 (2012).","journal-title":"OMICS"},{"issue":"1","key":"21401_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","volume":"9","author":"ZR Chalmers","year":"2017","unstructured":"Chalmers, Z. R. et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 9 (1), 34. https:\/\/doi.org\/10.1186\/s13073-017-0424-2 (2017).","journal-title":"Genome Med."},{"key":"21401_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.pharmthera.2018.04.004","volume":"189","author":"M Baretti","year":"2018","unstructured":"Baretti, M. & Le, D. T. DNA mismatch repair in cancer. Pharmacol. Ther. 189, 45\u201362. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.04.004 (2018).","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"21401_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-019-0805-7","volume":"12","author":"S Ma","year":"2019","unstructured":"Ma, S. et al. The interplay between m6A RNA methylation and noncoding RNA in cancer. J. Hematol. Oncol. 12 (1), 121. https:\/\/doi.org\/10.1186\/s13045-019-0805-7 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"21401_CR34","doi-asserted-by":"publisher","first-page":"556497","DOI":"10.3389\/fonc.2020.556497","volume":"10","author":"X Niu","year":"2020","unstructured":"Niu, X. et al. Landscape of N6-Methyladenosine modification patterns in human ameloblastoma. Front. Oncol. 10, 556497. https:\/\/doi.org\/10.3389\/fonc.2020.556497 (2020).","journal-title":"Front. Oncol."},{"key":"21401_CR35","doi-asserted-by":"publisher","first-page":"e921863","DOI":"10.12659\/MSM.921863","volume":"26","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. Downregulated miR-524-5p participates in the tumor microenvironment of ameloblastoma by targeting the interleukin-33 (IL-33)\/suppression of tumorigenicity 2 (ST2) axis. Med. Sci. Monit. 26, e921863. https:\/\/doi.org\/10.12659\/MSM.921863 (2020).","journal-title":"Med. Sci. Monit."},{"issue":"6","key":"21401_CR36","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.7150\/thno.52366","volume":"11","author":"J Li","year":"2021","unstructured":"Li, J., Liang, L., Yang, Y., Li, X. & Ma, Y. N6-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction. Theranostics 11 (6), 2581\u20132593. https:\/\/doi.org\/10.7150\/thno.52366 (2021).","journal-title":"Theranostics"},{"issue":"1","key":"21401_CR37","doi-asserted-by":"publisher","first-page":"111905","DOI":"10.1016\/j.celrep.2022.111905","volume":"42","author":"TTT Nguyen","year":"2023","unstructured":"Nguyen, T. T. T. et al. Tryptophan-dependent and -independent secretions of tryptophanyl - tRNA synthetase mediate innate inflammatory responses. Cell. Rep. 42 (1), 111905. https:\/\/doi.org\/10.1016\/j.celrep.2022.111905 (2023).","journal-title":"Cell. Rep."},{"issue":"4-5","key":"21401_CR38","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cytogfr.2005.05.004","volume":"16","author":"Q Jiang","year":"2005","unstructured":"Jiang, Q. et al. Cell biology of IL-7, a key Lymphotrophin. Cytokine Growth Factor. Rev. 16 (4-5), 513\u2013533. https:\/\/doi.org\/10.1016\/j.cytogfr.2005.05.004 (2005).","journal-title":"Cytokine Growth Factor. Rev."},{"issue":"11","key":"21401_CR39","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.4049\/jimmunol.174.11.6571","volume":"174","author":"TJ Fry","year":"2005","unstructured":"Fry, T. J. & Mackall, C. L. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 174 (11), 6571\u20136576. https:\/\/doi.org\/10.4049\/jimmunol.174.11.6571 (2005).","journal-title":"J. Immunol."},{"issue":"4","key":"21401_CR40","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1084\/jem.181.4.1519","volume":"181","author":"UV Freeden-Jeffry","year":"1995","unstructured":"Freeden-Jeffry, U. V. et al. Lymphopenia in Interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181 (4), 1519\u20131526. https:\/\/doi.org\/10.1084\/jem.181.4.1519 (1995).","journal-title":"J. Exp. Med."},{"issue":"5","key":"21401_CR41","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1084\/jem.180.5.1955","volume":"180","author":"JJ Peschon","year":"1994","unstructured":"Peschon, J. J. et al. Early lymphocyte expansion is severely impaired in Interleukin 7 receptor-deficient mice. J. Exp. Med. 180 (5), 1955\u20131960. https:\/\/doi.org\/10.1084\/jem.180.5.1955 (1994).","journal-title":"J. Exp. Med."},{"issue":"4","key":"21401_CR42","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/3877","volume":"20","author":"A Puel","year":"1998","unstructured":"Puel, A., Ziegler, S. F., Buckley, R. H. & Leonard, W. J. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat. Genet. 20 (4), 394\u2013397. https:\/\/doi.org\/10.1038\/3877 (1998).","journal-title":"Nat. Genet."},{"issue":"8","key":"21401_CR43","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1046\/j.1537-2995.2000.40111421.x","volume":"96","author":"CM Roifman","year":"2000","unstructured":"Roifman, C. M., Zhang, J., Chitayat, D. & Sharfe, N. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood 96 (8), 2803\u20132807. https:\/\/doi.org\/10.1046\/j.1537-2995.2000.40111421.x (2000).","journal-title":"Blood"},{"issue":"3","key":"21401_CR44","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/bjc.2015.233","volume":"113","author":"SJ Thomas","year":"2015","unstructured":"Thomas, S. J., Snowden, J. A., Zeidler, M. P. & Danson, S. J. The role of JAK\/STAT signalling in the pathogenesis, prognosis and treatment of solid tumors. Br. J. Cancer. 113 (3), 365\u2013371. https:\/\/doi.org\/10.1038\/bjc.2015.233 (2015).","journal-title":"Br. J. Cancer"},{"issue":"6","key":"21401_CR45","doi-asserted-by":"publisher","first-page":"108367","DOI":"10.1016\/j.celrep.2020.108367","volume":"33","author":"TTT Nguyen","year":"2020","unstructured":"Nguyen, T. T. T. et al. Tryptophanyl-tRNA synthetase 1 signals activate TREM-1 via TLR2 and TLR4 in macrophages. Cell. Rep. 33 (6), 108367. https:\/\/doi.org\/10.1016\/j.celrep.2020.108367 (2020).","journal-title":"Cell. Rep."},{"issue":"2","key":"21401_CR46","doi-asserted-by":"publisher","first-page":"e01291","DOI":"10.1128\/JVI.01291-18","volume":"93","author":"HC Lee","year":"2019","unstructured":"Lee, H. C. et al. Released tryptophanyl-tRNA synthetase stimulates innate immune responses against viral infection. J. Virol. 93 (2), e01291\u2013e01218. https:\/\/doi.org\/10.1128\/JVI.01291-18 (2019).","journal-title":"J. Virol."},{"key":"21401_CR47","doi-asserted-by":"publisher","first-page":"16191","DOI":"10.1038\/nmicrobiol.2017.15","volume":"2","author":"YH Ahn","year":"2017","unstructured":"Ahn, Y. H. et al. Secreted tryptophanyl-tRNA synthetase as a primary defence system against infection. Nat. Microbiol. 2, 16191. https:\/\/doi.org\/10.1038\/nmicrobiol.2017.15 (2017).","journal-title":"Nat. Microbiol."},{"key":"21401_CR48","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12964-025-02138-7","volume":"23","author":"L Zheng","year":"2025","unstructured":"Zheng, L. et al. Cancer-associated fibroblasts: a pivotal regulator of tumor microenvironment in the context of radiotherapy. Cell. Commun. Signal. 23, 147. https:\/\/doi.org\/10.1186\/s12964-025-02138-7 (2025).","journal-title":"Cell. Commun. Signal."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21401-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21401-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21401-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:02:46Z","timestamp":1761962566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21401-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21401"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21401-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The blood and pathological sections utilized in this study were residual samples obtained following routine clinical examination. Any private information has been appropriately redacted, ensuring no potential harm or breach of confidentiality to the patients involved. This study was approved by the Ethics Committee of Nanjing Hospital of Traditional Chinese Medicine. All procedures were conducted in accordance with the Declaration of Helsinki and relevant guidelines and regulations. Informed consent was obtained from all participants or their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave their consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"37495"}}